Enhancing pharmacologic effects in the treatment of depression in women.
The prevalence of depressive disorders in women is twice that in men. This gender difference emerges around the time of puberty and persists through the childbearing years. Reproductive events and psychosocial factors are important influences on depression in women. Women often present with atypical depressive symptoms and comorbid disorders that can complicate both diagnosis and treatment. Sex differences in pharmacokinetics have been noted, as well as differences in antidepressant treatment response. While sleep disturbances, sexual dysfunction, and weight gain may be part of the constellation of depressive symptoms, they are also important considerations in selecting a treatment option for depressed women.
Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0710, USA.
S G
SG
Kornstein
G
G
McEnany
D000928:Antidepressive Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D015995:Prevalence; D012737:Sex Factors; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced / Q000188:drug therapy / Q000453:epidemiology; D012893:Sleep Wake Disorders / Q000139:chemically induced / Q000188:drug therapy / Q000453:epidemiology; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
D000928:Antidepressive Agents